In a vaccine market with severe homogenization, differentiation is the strongest competitive advantage. AIM's iterative process high-efficiency diploid rabies vaccine demonstrates significant ...
This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...
Verndari is one of four companies selected by BARDA to develop alternative vaccine delivery technologies for existing and emerging infectious diseases. Verndari’s VaxiPatch™ technology shows ...
The CARES Act requires the Government Accountability Office (GAO) to look at the government’s response to the COVID-19 pandemic, including vaccine development. The government watchdog has found that, ...
This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...
Moderna and Merck's melanoma vaccine, combined with Keytruda, could halve cancer recurrence risk, marking a breakthrough in ...
Bayer's Monsanto has sued Pfizer, BioNTech and Moderna for allegedly misusing its messenger RNA technology in COVID vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results